~ Selected good articles from Yihuanan PV AI experts' insights, welcome to follow~

Brief introduction and enlightenment of WHO's guide on "Ethics and Governance of Artificial Intelligence in the Health and Health Field" Wang Tao1, Song Haibo1, Wang Qing2, Hou Yongfang1, Liu Hongliang1, Zhang Lin2

Summary of this article:

Purpose

Systematically introduce the World Health Organization (WHO) Guidelines for the Ethics and Governance of Artificial Intelligence in the Field of Health ("Guidelines"), as well as the ethics and governance of medical and health artificial intelligence (AI) in other major countries and regions in the world and my country, with a view to Provide reference for the future formulation of AI-related ethical guidelines in the field of drug supervision in my country.

method

Introduce the formulation, main content, ethical principles and other contents involved in the "Guidelines"; by consulting the literature and regulatory agency websites, introduce the overview of AI ethics and governance in the medical and health field of the United States, the European Union, and my country's government departments and related organizations.

result

The "Guidelines" elaborates on the six core ethical principles for the healthy development and use of AI in the medical and health field; the United States, the European Union, and our government departments and related organizations focus on the principles of fairness and justice, respect for privacy, security and controllability, shared responsibility, openness and transparency, etc. A series of policies and regulations on AI ethics and governance have been formulated.

in conclusion

Drawing on the WHO and foreign experience, it is recommended that my country's drug regulatory agencies actively formulate and implement regulatory standards or relevant guidelines for new AI technologies throughout the life cycle, and strengthen AI ethical governance in terms of transparency of AI drugs and medical device product technologies.

Original link and download:

~About Yi Huan'an~

We have devoted ourselves to the field of pharmacovigilance and have accumulated more than 20 years of rich experience. Adhering to the mission of "empowering customers to improve patient safety", we actively expand our global business landscape, and have established companies in China, Japan, South Korea, the United States and many places in the EU.

We have successfully obtained authoritative certifications such as SOC2 and GDPR, combining the advantages of globalization and localized services. We are a professional provider of PV IT services and AI automation tools.